cannabis and glp 1 Glucagon-like peptide-1 receptor agonists risk of substance use disorders among US veterans with type 2 diabetes: cohort study GLP-1s Like Ozempic May Be

Insurers and employers face tough decisions on how far to extend GLP1 coverage beyond diabetes Public and private drug plans in Canada are facing growing pressure over how to fund GLP-1 drugs, such as Ozempic, as demand extends beyond diabetes to obesity and weight management

This molecule could be a hormone, neurotransmitter, or another protein

Key Takeaways GLP-1 receptor agonists are mainly used for weight management and diabetes, but they also seem to affect the brain

Thats not a coincidence

The trials included 36,397 patients, 62.77% of whom were men and with a mean age of 58.0 4.3 years

We serve clients from Las Vegas NV, Summerlin South NV, Paradise NV, Winchester NV, Spring Valley NV, and surrounding areas